Cy. Shiau et al., RADIOSURGERY FOR BRAIN METASTASES - RELATIONSHIP OF DOSE AND PATTERN OF ENHANCEMENT TO LOCAL-CONTROL, International journal of radiation oncology, biology, physics, 37(2), 1997, pp. 375-383
Citations number
21
Categorie Soggetti
Oncology,"Radiology,Nuclear Medicine & Medical Imaging
Purpose: This study aimed to analyze dose, initial pattern of enhancem
ent, and other factors associated with freedom from progression (FFP)
of brain metastases after radiosurgery (RS). Methods and Materials: Al
l brain metastases treated with gamma-knife RS at the University of Ca
lifornia, San Francisco, from 1991 to 1994 were reviewed. Evaluable le
sions were those with follow-up magnetic resonance or computed tomogra
phic imaging. Actuarial FFP was calculated using the Kaplan-Meier meth
od, measuring FFP from the date of RS to the first imaging study showi
ng tumor progression. Controlled lesions were censored at the time of
the last imaging study. Multivariate analyses were performed using a s
tepwise Cox proportional hazards model. Results: Of 261 lesions treate
d in 119 patients, 219 lesions in 100 patients were evaluable. Major h
istologies included adenocarcinoma (86 lesions), melanoma (77), renal
cell carcinoma (21), and carcinoma not otherwise specified (17). The m
edian prescribed RS dose was 18.5 Gy (range, 10-22) and the median tum
or volume was 1.3 mi (range, 0.02-30.9). The initial pattern of contra
st enhancement was homogeneous in 68% of lesions, heterogeneous in 12%
, and ring-enhancing in 19%. The actuarial FFP was 82% at 6 months and
77% at 1 year for all lesions, and 93 and 90%, respectively, for 145
lesions receiving greater than or equal to 18 Gy. Multivariate analysi
s showed that longer FFP was significantly associated with higher pres
cribed RS dose, a homogeneous pattern of contrast enhancement, and a l
onger interval between primary diagnosis and RS. Adjusted for these fa
ctors, adenocarcinomas had longer FFP than melanomas. No significant d
ifferences in FFP were noted among lesions undergoing RS for recurrenc
e after prior radiotherapy (119 lesions), RS alone as initial treatmen
t (45), or RS boost (55). Conclusion: A minimum prescribed radiosurgic
al dose greater than or equal to 18 Gy yields excellent local control
of brain metastases. The influence of pattern of enhancement on local
control, a new finding in this retrospective analysis, needs to be con
firmed. (C) 1997 Elsevier Science Inc.